Livio Trentin received a Medical Doctor Degree from Padua University School of Medicine in 1983. From April 2015 to the present, he has been an associate professor of hematology at Padua University School of Medicine, Department of Medicine, Hematology Section. From 1998 to 2015, he was a researcher at Padua University School of Medicine, Dept. of Clinical and Experimental Medicine (SSD MED/09 and MED/15). He has been a member of the "Research Committee", Dept of Medicine, Padua University from 2005 to the present. From 2004 to 2011, he was a member of "The Scientific Committee", Dept. of Clinical and Experimental Medicine, Padua University School of Medicine. He is the author or co-author of more than 200 scientific papers with a total impact factor of 1.700. Total cites: about 6,339 by ISi since 1984; h-index: 45 according to ISi (Philadelphia). His research keywords include chronic lymphocytic leukemia and the jak2/stat3 pathway is constitutively activated and its inhibition leads to cell cell death unaffected by the protective bone marrow microenvironment.